Therapeutic effects of non-invasive, individualized, transcranial neuromodulation treatment for voiding dysfunction in multiple sclerosis patients: study protocol for a pilot clinical trial

BACKGROUND: Voiding dysfunction (VD) is a common neurogenic lower urinary tract dysfunction (NLUTD) in multiple sclerosis (MS) patients. Currently, the only effective management for VD and urinary retention in MS patients is catheterization, prompting us to look for novel therapeutic options beyond...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Khue, Shi, Zhaoyue, Karmonik, Christof, John, Blessy, Rajab, Hamida, Helekar, Santosh A., Boone, Timothy, Khavari, Rose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989407/
https://www.ncbi.nlm.nih.gov/pubmed/33757581
http://dx.doi.org/10.1186/s40814-021-00825-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989407/
https://www.ncbi.nlm.nih.gov/pubmed/33757581
http://dx.doi.org/10.1186/s40814-021-00825-z

Ejemplares similares